LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.25 | 27.76 | 218 | 6873 | 0.0317 | 0.2959 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.25 | 27.76 | 6079 | 6873 | 0.8844 | 0.9694 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 93.96 | 27.76 | 82 | 6849 | 0.0120 | 0.1460 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 93.96 | 27.76 | 4707 | 6849 | 0.6873 | 0.9078 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 93.96 | 27.76 | 209 | 6849 | 0.0305 | 0.2892 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 93.96 | 27.76 | 6214 | 6849 | 0.9073 | 0.9757 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 95.66 | 27.76 | 70 | 6712 | 0.0104 | 0.1239 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 95.66 | 27.76 | 4772 | 6712 | 0.7109 | 0.9156 | MN20160318_Q01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 95.66 | 27.76 | 228 | 6712 | 0.0340 | 0.3047 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 95.66 | 27.76 | 6350 | 6712 | 0.9460 | 0.9860 | MN20160318_Q01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 1.95 | 27.76 | 461 | 225 | 2.0476 | 1.5357 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 1.95 | 27.76 | 523 | 225 | 2.3230 | 1.6439 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 1.95 | 27.76 | 576 | 225 | 2.5584 | 1.7298 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 3.66 | 27.76 | 548 | 283 | 1.9301 | 1.4331 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 3.66 | 27.76 | 617 | 283 | 2.1731 | 1.5207 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 3.66 | 27.76 | 654 | 283 | 2.3034 | 1.5648 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 5.36 | 27.76 | 626 | 320 | 1.9541 | 1.4181 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | H12 |